Ricerc@Sapienza

Imbalance of the iron level in the body causes several diseases. In particular, the low level of iron, during pregnancy, is
responsible for the iron deficiency anemia, and even of neurodegenerative diseases. Although the treatment of iron
deficiency anemia with oral iron supplements has been known, this problem still afflicts many people. The aim of this work
was the development of a system able to release ferrous ions in a controlled manner. Controlled drug release for medical
applications, indeed, appears to be a very interesting alternative to a systemic therapy because it is assurance of treatment
continuity and drug stability and optimizes drug absorption. For this purpose, ferrous citrate (Fe(II)C) was synthesized by a
redox reaction between iron powder and citric acid. Fourier transform infrared spectroscopy (FTIR), 1,10-phenanthroline
and sodium thiocyanate colorimetric assays confirmed that only Fe(II)C was obtained by redox reaction. Afterward,
obtained Fe(II)C was embedded within a SiO2 matrix in different mass percentage, by means of a sol–gel route. FTIR
spectroscopy and simultaneous thermogravimetry/first-order derivative of thermogravimetry were used to confirm the
Fe(II)C presence in the silica matrix and to investigate the thermal behavior of the sol–gel materials, respectively. The
bioactivity test carried out by soaking the synthesized drug delivery systems in a simulated body fluid showed that the
biological properties of the silica matrix are not modified by the presence of Fe(II)C.